Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs
- 31 August 1987
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 336 (3) , 352-358
- https://doi.org/10.1007/bf00172690
Abstract
The present investigation was conducted to study systemic and regional haemodynamic effects of nicorandil, a potent coronary vasodilator, after intravenous or local intracoronary administration in anaesthetized or conscious pigs. Intravenous infusions of nicorandil for 10 min in both anaesthetized (15, 30, 75 and 150 μg · kg−1 · min−1) and conscious (20, 40 and 80 μg · kg−1 · min−1) pigs reduced arterial blood pressure, stroke volume, left ventricular end-diastolic pressure (LVEDP) and systemic vascular resistance, but increased heart rate and maxLVdP/dt. Since nicorandil decreased LVEDP at doses which did not affect arterial blood pressure, the drug may be considered as a more potent venodilator than arterial dilator. Nicorandil increased cardiac output only in conscious animals due to a more marked tachycardia (85% after 80 μg · kg−1 · min−1) than in anaesthetized animals (30% after 75 μg · kg−1 · min−1). The nicorandil-induced increase in heart rate and maxLVdP/dt, being substantially attenuated in conscious pigs after treatment with propranolol, can be ascribed to a reflex activation of the sympathetic nervous system following the fall in arterial pressure. Although cardiac output did not change in anaesthetized animals, intravenous infusions of nicorandil did cause a redistribution of blood flow in favour of organs such as the heart, adrenals, spleen, small intestine and brain at the expense of that to the stomach and kidneys; hepatic artery and skeletal muscle blood flow did not change. The increase in myocardial blood flow, primarily to the subepicardial layers, was associated with an enhancement in coronary venous oxygen content and was also noticed after intracoronary infusions of nicorandil (0.6, 1.5, 3 and 6 μg · kg−1 · min−1). The above cardiovascular profile suggests a possible usefulness of nicorandil in angina pectoris as well as congestive heart failure. However, caution is needed because the strong hypotensive action and reflex-mediated tachycardia may under certain conditions aggravate myocardial ischaemia, particularly in the subendocardial layers.This publication has 27 references indexed in Scilit:
- Regional vascular adjustments during recovery from myocardial infarction in ratsJournal of the American College of Cardiology, 1986
- USEFULNESS OF PIMOBENDAN IN THE TREATMENT OF HEART-FAILURE1986
- Acute Systemic and Regional Hemodynamic Effects of Felodipine, a New Calcium Antagonist, in Conscious Renal Hypertensive RabbitsJournal of Cardiovascular Pharmacology, 1984
- EFFECTS OF NICORANDIL, A NEW ANTIANGINAL AGENT, AND NIFEDIPINE ON COLLATERAL BLOOD-FLOW IN A CHRONIC CORONARY-OCCLUSION MODEL1984
- COMPARATIVE ACTIONS OF DIHYDROPYRIDINE SLOW CHANNEL CALCIUM BLOCKING-AGENTS IN CONSCIOUS DOGS - SYSTEMIC AND CORONARY HEMODYNAMICS WITH AND WITHOUT COMBINED BETA-ADRENERGIC-BLOCKADE1984
- Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.Circulation Research, 1983
- Cardiovascular Effects of a New Coronary Vasodilator N-(2-Hydroxyethyl)nicotinamide Nitrate (SG-75)Journal of Cardiovascular Pharmacology, 1981
- Effects of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) on methacholine-induced ecg changes in intact anesthetized rats.The Japanese Journal of Pharmacology, 1981
- Computer programs for the radioactive microsphere technique: Determination of regional blood flows and other haemodynamic variables in different experimental circumstancesComputer Programs in Biomedicine, 1980
- Effect of 2-Nicotinamidethyl Nitrate (SG 75) on Coronary CirculationJapanese Heart Journal, 1978